Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1995 Jun;63(6):2133–2140. doi: 10.1128/iai.63.6.2133-2140.1995

Biological activities of staphylococcal enterotoxin type A mutants with N-terminal substitutions.

T O Harris 1, M J Betley 1
PMCID: PMC173277  PMID: 7768592

Abstract

The purpose of this study was to examine the importance of certain N-terminal amino acid residues of staphylococcal enterotoxin type A (SEA) for biological activity. The results confirm our previous observation that Asn-25, Phe-47, and Leu-48 are important for SEA's emetic and superantigen activities. Substitutions at six other sites (Leu-12, Lys-14, Ser-16, Asp-45, Gln-46, and Thr-51) did not reveal any additional residues required for biological activity. Mutant SEAs with substitutions at 25, 47, or 48 all had decreased T-cell stimulatory activity, with the mutants at position 47 being the most defective. Results of a competition assay for binding to the major histocompatibility complex (MHC) class II-expressing cell line Raji suggested that the decreased superantigen activities of the mutants with substitutions at positions 47 and 48 are due to poor interactions with MHC class II molecules, whereas the defects of the mutants at position 25 are a consequence of faulty interactions with T-cell receptors. With respect to emetic activity in rhesus monkeys, the mutants at position 25 or 48 exhibited decreased but significant activity. Interestingly, the two mutants at position 47 had different emetic activities; SEA-F47G was nonemetic when administered intragastrically at 500 micrograms per animal, whereas SEA-F47S was emetic at this dosage. Since the mutants at position 47 were equally defective for superantigen activity, this further supports our previous suggestion of an incomplete correlation between SEA's emetic and superantigen activities.

Full Text

The Full Text of this article is available as a PDF (375.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alber G., Hammer D. K., Fleischer B. Relationship between enterotoxic- and T lymphocyte-stimulating activity of staphylococcal enterotoxin B. J Immunol. 1990 Jun 15;144(12):4501–4506. [PubMed] [Google Scholar]
  2. Betley M. J., Borst D. W., Regassa L. B. Staphylococcal enterotoxins, toxic shock syndrome toxin and streptococcal pyrogenic exotoxins: a comparative study of their molecular biology. Chem Immunol. 1992;55:1–35. [PubMed] [Google Scholar]
  3. Betley M. J., Löfdahl S., Kreiswirth B. N., Bergdoll M. S., Novick R. P. Staphylococcal enterotoxin A gene is associated with a variable genetic element. Proc Natl Acad Sci U S A. 1984 Aug;81(16):5179–5183. doi: 10.1073/pnas.81.16.5179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Betley M. J., Mekalanos J. J. Nucleotide sequence of the type A staphylococcal enterotoxin gene. J Bacteriol. 1988 Jan;170(1):34–41. doi: 10.1128/jb.170.1.34-41.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bohach G. A., Fast D. J., Nelson R. D., Schlievert P. M. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit Rev Microbiol. 1990;17(4):251–272. doi: 10.3109/10408419009105728. [DOI] [PubMed] [Google Scholar]
  6. Bohach G. A., Handley J. P., Schlievert P. M. Biological and immunological properties of the carboxyl terminus of staphylococcal enterotoxin C1. Infect Immun. 1989 Jan;57(1):23–28. doi: 10.1128/iai.57.1.23-28.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Buelow R., O'Hehir R. E., Schreifels R., Kummerehl T. J., Riley G., Lamb J. R. Localization of the immunologic activity in the superantigen Staphylococcal enterotoxin B using truncated recombinant fusion proteins. J Immunol. 1992 Jan 1;148(1):1–6. [PubMed] [Google Scholar]
  8. Chintagumpala M. M., Mollick J. A., Rich R. R. Staphylococcal toxins bind to different sites on HLA-DR. J Immunol. 1991 Dec 1;147(11):3876–3881. [PubMed] [Google Scholar]
  9. Fraser J. D. High-affinity binding of staphylococcal enterotoxins A and B to HLA-DR. Nature. 1989 May 18;339(6221):221–223. doi: 10.1038/339221a0. [DOI] [PubMed] [Google Scholar]
  10. Fraser J. D., Urban R. G., Strominger J. L., Robinson H. Zinc regulates the function of two superantigens. Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5507–5511. doi: 10.1073/pnas.89.12.5507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Griggs N. D., Pontzer C. H., Jarpe M. A., Johnson H. M. Mapping of multiple binding domains of the superantigen staphylococcal enterotoxin A for HLA. J Immunol. 1992 Apr 15;148(8):2516–2521. [PubMed] [Google Scholar]
  12. Grossman D., Van M., Mollick J. A., Highlander S. K., Rich R. R. Mutation of the disulfide loop in staphylococcal enterotoxin A. Consequences for T cell recognition. J Immunol. 1991 Nov 15;147(10):3274–3281. [PubMed] [Google Scholar]
  13. Harris T. O., Grossman D., Kappler J. W., Marrack P., Rich R. R., Betley M. J. Lack of complete correlation between emetic and T-cell-stimulatory activities of staphylococcal enterotoxins. Infect Immun. 1993 Aug;61(8):3175–3183. doi: 10.1128/iai.61.8.3175-3183.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Harris T. O., Hufnagle W. O., Betley M. J. Staphylococcal enterotoxin type A internal deletion mutants: serological activity and induction of T-cell proliferation. Infect Immun. 1993 May;61(5):2059–2068. doi: 10.1128/iai.61.5.2059-2068.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Herman A., Labrecque N., Thibodeau J., Marrack P., Kappler J. W., Sekaly R. P. Identification of the staphylococcal enterotoxin A superantigen binding site in the beta 1 domain of the human histocompatibility antigen HLA-DR. Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):9954–9958. doi: 10.1073/pnas.88.22.9954. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hoffmann M. L., Jablonski L. M., Crum K. K., Hackett S. P., Chi Y. I., Stauffacher C. V., Stevens D. L., Bohach G. A. Predictions of T-cell receptor- and major histocompatibility complex-binding sites on staphylococcal enterotoxin C1. Infect Immun. 1994 Aug;62(8):3396–3407. doi: 10.1128/iai.62.8.3396-3407.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hudson K. R., Robinson H., Fraser J. D. Two adjacent residues in staphylococcal enterotoxins A and E determine T cell receptor V beta specificity. J Exp Med. 1993 Jan 1;177(1):175–184. doi: 10.1084/jem.177.1.175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hufnagle W. O., Tremaine M. T., Betley M. J. The carboxyl-terminal region of staphylococcal enterotoxin type A is required for a fully active molecule. Infect Immun. 1991 Jun;59(6):2126–2134. doi: 10.1128/iai.59.6.2126-2134.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Ikejima T., Dinarello C. A., Gill D. M., Wolff S. M. Induction of human interleukin-1 by a product of Staphylococcus aureus associated with toxic shock syndrome. J Clin Invest. 1984 May;73(5):1312–1320. doi: 10.1172/JCI111334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Ikejima T., Okusawa S., van der Meer J. W., Dinarello C. A. Induction by toxic-shock-syndrome toxin-1 of a circulating tumor necrosis factor-like substance in rabbits and of immunoreactive tumor necrosis factor and interleukin-1 from human mononuclear cells. J Infect Dis. 1988 Nov;158(5):1017–1025. doi: 10.1093/infdis/158.5.1017. [DOI] [PubMed] [Google Scholar]
  21. Iordănescu S. Recombinant plasmid obtained from two different, compatible staphylococcal plasmids. J Bacteriol. 1975 Nov;124(2):597–601. doi: 10.1128/jb.124.2.597-601.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Irwin M. J., Hudson K. R., Fraser J. D., Gascoigne N. R. Enterotoxin residues determining T-cell receptor V beta binding specificity. Nature. 1992 Oct 29;359(6398):841–843. doi: 10.1038/359841a0. [DOI] [PubMed] [Google Scholar]
  23. Jardetzky T. S., Brown J. H., Gorga J. C., Stern L. J., Urban R. G., Chi Y. I., Stauffacher C., Strominger J. L., Wiley D. C. Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature. 1994 Apr 21;368(6473):711–718. doi: 10.1038/368711a0. [DOI] [PubMed] [Google Scholar]
  24. Jett M., Neill R., Welch C., Boyle T., Bernton E., Hoover D., Lowell G., Hunt R. E., Chatterjee S., Gemski P. Identification of staphylococcal enterotoxin B sequences important for induction of lymphocyte proliferation by using synthetic peptide fragments of the toxin. Infect Immun. 1994 Aug;62(8):3408–3415. doi: 10.1128/iai.62.8.3408-3415.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kappler J. W., Herman A., Clements J., Marrack P. Mutations defining functional regions of the superantigen staphylococcal enterotoxin B. J Exp Med. 1992 Feb 1;175(2):387–396. doi: 10.1084/jem.175.2.387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Karp D. R., Long E. O. Identification of HLA-DR1 beta chain residues critical for binding staphylococcal enterotoxins A and E. J Exp Med. 1992 Feb 1;175(2):415–424. doi: 10.1084/jem.175.2.415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Kotzin B. L., Leung D. Y., Kappler J., Marrack P. Superantigens and their potential role in human disease. Adv Immunol. 1993;54:99–166. doi: 10.1016/s0065-2776(08)60534-9. [DOI] [PubMed] [Google Scholar]
  28. Kreiswirth B. N., Löfdahl S., Betley M. J., O'Reilly M., Schlievert P. M., Bergdoll M. S., Novick R. P. The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage. Nature. 1983 Oct 20;305(5936):709–712. doi: 10.1038/305709a0. [DOI] [PubMed] [Google Scholar]
  29. Merryman P., Silver J., Gregersen P. K., Solomon G., Winchester R. A novel association of DQ alpha and DQ beta genes in the DRw10 haplotype. Determination of a DQw1 specificity by the DQ beta-chain. J Immunol. 1989 Sep 15;143(6):2068–2073. [PubMed] [Google Scholar]
  30. Messing J., Vieira J. A new pair of M13 vectors for selecting either DNA strand of double-digest restriction fragments. Gene. 1982 Oct;19(3):269–276. doi: 10.1016/0378-1119(82)90016-6. [DOI] [PubMed] [Google Scholar]
  31. Metzroth B., Marx T., Linnig M., Fleischer B. Concomitant loss of conformation and superantigenic activity of staphylococcal enterotoxin B deletion mutant proteins. Infect Immun. 1993 Jun;61(6):2445–2452. doi: 10.1128/iai.61.6.2445-2452.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Mollick J. A., McMasters R. L., Grossman D., Rich R. R. Localization of a site on bacterial superantigens that determines T cell receptor beta chain specificity. J Exp Med. 1993 Feb 1;177(2):283–293. doi: 10.1084/jem.177.2.283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. NOVICK R. P. ANALYSIS BY TRANSDUCTION OF MUTATIONS AFFECTING PENICILLINASE FORMATION IN STAPHYLOCOCCUS AUREUS. J Gen Microbiol. 1963 Oct;33:121–136. doi: 10.1099/00221287-33-1-121. [DOI] [PubMed] [Google Scholar]
  34. Patel A. H., Foster T. J., Pattee P. A. Physical and genetic mapping of the protein A gene in the chromosome of Staphylococcus aureus 8325-4. J Gen Microbiol. 1989 Jul;135(7):1799–1807. doi: 10.1099/00221287-135-7-1799. [DOI] [PubMed] [Google Scholar]
  35. Pontzer C. H., Griggs N. D., Johnson H. M. Agonist properties of a microbial superantigen peptide. Biochem Biophys Res Commun. 1993 Jun 30;193(3):1191–1197. doi: 10.1006/bbrc.1993.1751. [DOI] [PubMed] [Google Scholar]
  36. Pontzer C. H., Russell J. K., Johnson H. M. Localization of an immune functional site on staphylococcal enterotoxin A using the synthetic peptide approach. J Immunol. 1989 Jul 1;143(1):280–284. [PubMed] [Google Scholar]
  37. Reck B., Scheuber P. H., Londong W., Sailer-Kramer B., Bartsch K., Hammer D. K. Protection against the staphylococcal enterotoxin-induced intestinal disorder in the monkey by anti-idiotypic antibodies. Proc Natl Acad Sci U S A. 1988 May;85(9):3170–3174. doi: 10.1073/pnas.85.9.3170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Robbins R., Gould S., Bergdoll M. Detecting the enterotoxigenicity of Staphylococcus aureus strains. Appl Microbiol. 1974 Dec;28(6):946–950. doi: 10.1128/am.28.6.946-950.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Rosenberg S. A., Lotze M. T., Muul L. M., Chang A. E., Avis F. P., Leitman S., Linehan W. M., Robertson C. N., Lee R. E., Rubin J. T. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. N Engl J Med. 1987 Apr 9;316(15):889–897. doi: 10.1056/NEJM198704093161501. [DOI] [PubMed] [Google Scholar]
  40. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463–5467. doi: 10.1073/pnas.74.12.5463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Scheuber P. H., Golecki J. R., Kickhöfen B., Scheel D., Beck G., Hammer D. K. Skin reactivity of unsensitized monkeys upon challenge with staphylococcal enterotoxin B: a new approach for investigating the site of toxin action. Infect Immun. 1985 Dec;50(3):869–876. doi: 10.1128/iai.50.3.869-876.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Scholl P. R., Diez A., Geha R. S. Staphylococcal enterotoxin B and toxic shock syndrome toxin-1 bind to distinct sites on HLA-DR and HLA-DQ molecules. J Immunol. 1989 Oct 15;143(8):2583–2588. [PubMed] [Google Scholar]
  43. See R. H., Krystal G., Chow A. W. Binding competition of toxic shock syndrome toxin 1 and other staphylococcal exoproteins for receptors on human peripheral blood mononuclear cells. Infect Immun. 1990 Jul;58(7):2392–2396. doi: 10.1128/iai.58.7.2392-2396.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. See R. H., Krystal G., Chow A. W. Receptors for toxic shock syndrome toxin-1 and staphylococcal enterotoxin A on human blood monocytes. Can J Microbiol. 1992 Sep;38(9):937–944. doi: 10.1139/m92-151. [DOI] [PubMed] [Google Scholar]
  45. Singh B. R., Betley M. J. Comparative structural analysis of staphylococcal enterotoxins A and E. J Biol Chem. 1989 Mar 15;264(8):4404–4411. [PubMed] [Google Scholar]
  46. Spero L., Morlock B. A. Biological activities of the peptides of staphylococcal enterotoxin C formed by limited tryptic hydrolysis. J Biol Chem. 1978 Dec 25;253(24):8787–8791. [PubMed] [Google Scholar]
  47. Stelma G. N., Jr, Bergdoll M. S. Inactivation of staphylococcal enterotoxin A by chemical modification. Biochem Biophys Res Commun. 1982 Mar 15;105(1):121–126. doi: 10.1016/s0006-291x(82)80019-3. [DOI] [PubMed] [Google Scholar]
  48. Swaminathan S., Furey W., Pletcher J., Sax M. Crystal structure of staphylococcal enterotoxin B, a superantigen. Nature. 1992 Oct 29;359(6398):801–806. doi: 10.1038/359801a0. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES